Cargando…
Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the deadly disease known as coronavirus disease 2019 (COVID-19) that has reached pandemic proportions. Currently, there is no definitive treatment for COVID-19, although many vaccines have been developed. The World Health O...
Autores principales: | Shiravi, Amir Abbas, Ardekani, Ali, Sheikhbahaei, Erfan, Heshmat-Ghahdarijani, Kiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629102/ https://www.ncbi.nlm.nih.gov/pubmed/34845662 http://dx.doi.org/10.1007/s40119-021-00248-0 |
Ejemplares similares
-
Alterations of Lipid Profile in COVID-19: A Narrative Review
por: Rezaei, Abbas, et al.
Publicado: (2022) -
Co-infection between the severe acute respiratory syndrome coronavirus 2 and the influenza Type B in Isfahan, Iran
por: Heshmat-Ghahdarijani, Kiyan, et al.
Publicado: (2021) -
Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox
por: Javanmard, Shaghayegh Haghjooy, et al.
Publicado: (2020) -
Metolazone Add-On Therapy in Heart Failure: A Cohort Study from Persian Registry of Cardiovascular Disease/Heart Failure (PROVE/HF)
por: Rahimi, Farzad, et al.
Publicado: (2021) -
Design and methodology of heart failure registry: Results of the Persian registry of cardiovascular disease
por: Givi, Mahshid, et al.
Publicado: (2019)